Evolv Technologies Holdings, Inc.
EVLVNasdaqTechnology · Computer Peripheral Equipment, NEC · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $145.9M | $103.9M | $20.1M | $17.6M | $3.7M | $4.8M |
| Operating income | −$48.5M | −$82.3M | −$22.6M | −$49.8M | −$9.0M | −$26.9M |
| Net income | −$33.1M | −$54.0M | −$28.7M | −$40.1M | −$13.5M | −$27.4M |
| Total assets | $304.4M | $268.1M | $304.7M | $332.3M | $362.9M | $21.8M |
| Total liabilities | $185.0M | $150.4M | $101.3M | $72.8M | $72.6M | $30.7M |
| Equity | $119.4M | $117.7M | $144.1M | $259.6M | $290.3M | −$84.8M |
| EPS (diluted) | $-0.20 | $-0.34 | $-0.20 | $-0.28 | $-1.29 | $-3.07 |
| Shares out. | 163.5M | 152.2M | 148.0M | 143.3M | 142.7M | 9.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −33.2%
- Net margin
- −22.7%
- Return on equity
- −27.7%
- Return on assets
- −10.9%
- Return on capital (ROCE)
- −26.7%
- Liabilities / assets
- 60.8%
- Debt / equity
- 1.55×
- Book value / share
- $0.73
- Revenue growth (YoY)
- 40.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -3.93distress
- Accruals / assets
- −17.0%clean
- Beneish M-Score
- -3.07normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 2 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2022
- NT 10-Qmissed a reporting deadline ↗May 18, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- General Catalyst Group Management Holdings Gp, LlcPassive (13G)Apr 17, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Gates Frontier, LlcPassive (13G)Sep 22, 2025
- Data Collective Iv, L.P.Activist (13D)Aug 22, 2025
- Stoic Point Capital Management LlcActivist (13D)Aug 19, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Ellenbogen MichaelDirector | May 15, 2026 | Option exercise | 80,745 | $0.24 |
| Kutsor George COfficer — Chief Financial Officer | May 1, 2026 | Option exercise | 138,888 | $0.00 |
| Ellenbogen MichaelDirector | Apr 15, 2026 | Option exercise | 80,745 | $0.24 |
| Ellenbogen MichaelDirector | Mar 6, 2026 | Sell | 91,771 | $5.10 |
| Ellenbogen MichaelDirector | Mar 1, 2026 | Option exercise | 57,392 | $0.00 |
| Chitkara AnilOfficer — Founder & Chief Growth Officer | Mar 1, 2026 | Option exercise | 53,430 | $0.00 |
| Ellenbogen MichaelDirector | Feb 17, 2026 | Option exercise | 80,745 | $0.24 |
| Ellenbogen MichaelDirector | Jan 16, 2026 | Option exercise | 80,745 | $0.24 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 8.2M | 2.0 | +18.1% |
| Apr 30, 2026 | 7.0M | 3.1 | -5.4% |
| Apr 15, 2026 | 7.4M | 3.1 | -19.8% |
| Mar 31, 2026 | 9.2M | 2.7 | -24.4% |
| Mar 13, 2026 | 12.2M | 2.7 | +29.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 12, 2026
- Results of operationsMar 10, 2026
- Director / officer change · Regulation FD disclosureFeb 12, 2026
- Results of operationsNov 13, 2025
- Results of operations · Director / officer changeAug 14, 2025
- Entered a material agreementJul 30, 2025
- Regulation FD disclosureJul 1, 2025
- Shareholder voteJun 23, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.